Related Experiment Video
Updated: Sep 14, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
The impact of molecular diagnostic tests on patient outcomes
1Department of Pathology and Laboratory Medicine, Albany Medical College, New York, USA. jeffrey_ross@ccgateway.amc.edu
Abstract:
In order for the benefits of molecular pathology to outweigh its inherent costs, the procedures must be integrated into the assessment of the total disease management to realize the true impact of their financial and clinical outcomes. Major financial and patient outcome benefits are achievable from molecular testing by the ability to reduce the use of less-sensitive and less-specific tests and cause a decrease the use of unnecessary diagnostic procedures and ineffective therapies. In this review, the financial and patient care determinants of outcomes for molecular-based testing of disease predisposition, screening, early detection, and directed therapy are presented.
More Related Videos
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Modern Molecular Taxonomy
Applications of Molecular Taxonomy
Rapid Identification of Pathogens
Automated Microbial Diagnostics

